Connect with us

CitiusTech Wins the 2019 Innovators Award for the Best Value-Based Care Solution

Published

on

Reading Time: 2 minutes

BI-Clinical RMM has been awarded for its ability to empower
healthcare organizations with the flexibility to build, edit and deploy
complex quality measures. It also includes the healthcare industry’s
largest library of 900+ pre-built clinical quality measures and KPIs.

PRINCETON, N.J.–(BUSINESS WIRE)–CitiusTech,
a leading provider of healthcare technology services and solutions,
today received the 2019
Innovators Award
in the Value-Based Care category for its BI-Clinical
RMM (BIC-RMM)
solution. For more than a decade, Healthcare
Innovation
has honored those on the forefront of healthcare IT
innovation with its Innovators Awards.

As the industry continues the transition towards value-based care, there
is an increasing need for organizations to measure and report clinical
quality metrics. One of the key challenges facing providers and payers
today is tracking hundreds of these complex and ever-changing clinical
quality measures (CQMs) and KPIs. BIC-RMM enables healthcare
organizations to build, edit and manage multiple rule types – CQMs,
alerts, cohorts – with an easy-to-use, do-it-yourself interface without
any dependency on IT/technical teams.

“Regulatory requirements are overwhelming in themselves, but additional
contractual and value-based payments are forcing payers and providers to
extend their quality strategy,” says Jeffrey Springer, SVP of Healthcare
Solutions at CitiusTech. “With BIC-RMM, healthcare organizations now
have the ability to build a comprehensive quality strategy with the
flexibility to manage all of their quality rules through a unified
solution.”

BIC-RMM has been adopted by several large health systems and leading
health plans to manage their quality initiatives and lower turnaround
time for building and deploying quality measures by up to 40 percent and
improve efficiency by up to 60 percent. By leveraging the BIC-RMM
solution, these organizations are better positioned to drive their
quality initiatives and value-based care programs.

A core strength of BIC-RMM is its ability to support major regulatory
programs including NCQA and CMS. It also simplifies rules management by
providing 900+ pre-built CQMs and KPIs (including MIPS / MACRA, HEDIS®,
QCDR) as well as custom quality measures.

*HEDIS is a registered trademark of the National Committee for Quality
Assurance (NCQA).

About CitiusTech
CitiusTech (www.citiustech.com)
is a specialist provider of healthcare technology services and solutions
to medical technology companies, providers, payers and life sciences
organizations, with over 3,500 professionals worldwide. CitiusTech’s
services and solutions include healthcare software development,
healthcare interoperability, regulatory compliance, BI/analytics,
consumer engagement, care coordination and population health management.
CitiusTech helps customers accelerate innovation in healthcare through
solutions and accelerators for clinical quality reporting, healthcare
big data, cloud computing, mobile health and predictive analytics. With
cutting-edge technology expertise, world-class service quality and a
global resource base, CitiusTech consistently delivers best-in-class
solutions and an unmatched cost advantage to healthcare clients
worldwide.

Contacts

Priyal Shah
CitiusTech
priyal.shah@citiustech.com

Cannabis

Sunniva Announces Closing Of Third Tranche Of Short Term Bridge Financing For Proceeds Of Cad $325,000

Published

on

Reading Time: 2 minutes

 

Sunniva Inc. (“Sunniva”, the “Company”, “we”, “our” or “us”) (CSE:SNN) (OTCQB:SNNVF), a North American provider of cannabis products and services, is pleased to announce that it has closed the third tranche of the Company’s non-brokered private placement (the “Offering“), previously announced on August 1, 2019 of CAD $325,000 for a total of 325,000 units of the Company (“Units“). In aggregate the total gross proceeds raised by the Offering was CAD $7.57 million and 7.57 million Units issued. Each Unit consists of a principal amount of unsecured promissory notes of the Company (“Promissory Notes“) and common share purchase warrants of the Company (“Warrants“).

As previously disclosed, proceeds of the Offering will be used to provide short term working capital for operations in California, capital costs at the Sunniva California Campus and general corporate purposes.

The Units issued under the Offering have the following terms:

Promissory Notes  

     Maturity: 

6 months from the closing date.

     Interest Rate:

10% (annual rate).

Warrants 

     Number of Warrants:   

0.40 Warrants per Unit (each Warrant entitles the holder to acquire one common

share of the Company at the Warrant Exercise Price).

     Warrant Exercise Price:  

CAD $2.50 per Warrant.

     Warrant Term:         

24 months from closing.

A finder’s fee of 5% payable in cash will be paid to certain investment advisors for introducing certain purchasers of Units to the Company.

The Promissory Notes and Warrants have not been registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the Promissory Notes or Warrants in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful.

For more information please visit: www.sunniva.com.

To be added to the Sunniva email distribution list please register at www.sunniva.com/email-alerts.mailto:

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

SOURCE Sunniva Inc.

Continue Reading

Cannabis

INTERCURE: CANNDOC signs strategic distribution agreement with S.L.E. of TEVA Pharmaceuticals

Published

on

Reading Time: 2 minutes

 

InterCure (TASE: INCR), announced that subsidiary Canndoc has entered into a strategic distribution agreement with Salomon, Levin, Elstein (S.L.E.,) which is owned by Teva Pharmaceuticals Industries (NYSE: and TASE: TEVA).

Under terms of the agreement, S.L.E. will distribute Canndoc’s GMP products to pharma clients, including hospitals, health maintenance organizations (HMOs) and all pharmacies in Israel, including pharmacy chains. In the future, as regulatory approvals allow, S.L.E. will provide logistics capability for exporting Canndoc’s products to countries that support regulations for the sale and distribution of cannabis products for medical use.

S.L.E. is one of Israel’s leading companies for providing health logistics services and distributes products from dozens of local and international companies. S.L.E. is licensed by the Israeli Ministry of Health, and also holds a GDP distribution license.

“Our agreement with S.L.E., Israel’s leading company in distributing medical products, creates a complete supporting platform for supplying Canndoc’s GMP products to any location in Israel and for countries with similar regulations,” said Canndoc’s Chairman Ehud BarakThrough its S.L.E. partnership, Canndoc has aligned itself with one of the most prominent pharmaceutical companies in the world, for the distribution of cannabis-based medical treatments to countries that recognize the value of these medicines for people in need.”

S.L.E. CEO Aviad Bossi adds, “The agreement brings together our well-established pharmaceutical distribution network with Canndoc’s high quality medical cannabis industry presence and market leadership. Beyond the operations in Israel, this agreement will provide Canndoc significant logistical capabilities that can support Canndoc’s exporting operations from Israel.”

The distribution agreement is set for a 3-year term and includes a mechanism for automatic extension periods of two years each.

Canndoc is one of the first licensed producers, with its GMP-approved medical cannabis Rx products being sold in pharmacies. The engagement in this distribution agreement will broaden Canndoc’s ability to distribute GMP products to its patients within the S.L.E. pharmacy network throughout Israel. In addition, S.L.E. will provide Canndoc significant logistical capabilities in the future supporting Canndoc’s ability to export its products to countries with consistent regulation for the sale and distribution of cannabis products for medical use.

 

SOURCE Canndoc

Continue Reading

Cannabis

Prairie Records Tops the Charts: Named Top Cannabis Retailer in Canada at Grow UP

Published

on

Reading Time: 1 minute

 

Westleaf Inc. (the “Company” or “Westleaf“) (TSX-V:WL) (OTCQB:WSLFF) is proud to announce its Prairie Records retail stores have been named top cannabis retailer in Canada at the GrowUP Conference & Expo. Singing a different tune in cannabis retail, the award win is a testament to how Prairie Records is offering Canadian’s a truly unprecedented purchasing experience.

“It is extremely gratifying to have Prairie Records be recognized at one of the industry’s largest events and to be able to stand out amongst a field of very worthy retail competitors,” says Adam Coates, Chief Commercial Officer at Westleaf and Retail Brand Strategist for Prairie Records. “We set out to make waves in a sea of sameness by creating an immersive experience like no other in the marketplace, and we are pleased and honoured to receive this, the first Grow UP Conference retail award.”

Ten companies were nominated in the Grow UP retail category at this year’s event, the first for the industry. Among the nominees were independent stores and well-known national chains. Prairie Records was recognized based on delivering an unparalleled consumer purchasing experience and creating a welcoming brand for cannabis consumers.

Westleaf has four Prairie Records stores open, three in the Saskatoon region and one in Calgary, which is hosting its grand opening tomorrow, September 14. The concept combines the tactile and immersive feel of a vinyl record store with a cannabis purchasing experience. Information about the cannabis strains and strengths are presented on album covers and the customer is enveloped in a warm and welcoming retail experience. The staff are well versed on the product offering and provide educational opportunities for both the experienced cannabis connoisseur as well as the novice consumer.

 

SOURCE Westleaf Inc.

Continue Reading

Trending Online

Grassnews is a news publishing website which digests / hand picks the latest news about the cannabis industry, and serves them to you daily.

Contact us: pressroom@grassnews.net

© Grassnews.net 2019 - part of PICANTE Media. All rights reserved. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania